CONVERSION AGREEMENTConversion Agreement • April 13th, 2011 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Agreement is entered into, effective as of September 28, 2009 (the “Effective Date”), by and between Northwest Biotherapeutics (“NWBT” or “the Company”), a Delaware corporation with its headquarters in Bethesda, Maryland, Toucan Capital Fund II, a Delaware limited liability company (“Toucan Capital”) with offices in Bethesda, Maryland, and Toucan Partners (“Toucan Partners”), a Delaware limited liability company with offices in Bethesda, Maryland.
RETENTION AND CONVERSION AGREEMENTRetention and Conversion Agreement • April 13th, 2011 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Agreement is entered into, effective as of September 28, 2009, by and between Northwest Biotherapeutics (“NWBT” or “the Company”), a Delaware corporation with its headquarters in Bethesda, Maryland, and Dr. Alton Boynton (“Dr. Boynton”), a resident of Kingston, Washington.
FORM OF LOAN AGREEMENT and PROMISSORY NOTE EXTENSION AGREEEMENTLoan Agreement and Promissory Note Extension Agreement • April 13th, 2011 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Loan Agreement and Promissory Note Extension Agreement (this “Extension Agreement”) is entered into by and between Northwest Biotherapeutics, Inc. , a Delaware corporation (the “ Maker ” or the “ Company ”) and ________, (“_______” or the “ Holder ”).
